NATALIE STONE: Open Payments
NPI 1588376396 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 114 payments from 14 companies in 2025. Trend: 2023 $1,165 · 2024 $2,154 · 2025 $1,553
Food & beverage: $1,553
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $331 |
| ABBVIE INC. | 28 | $286 |
| Vanda Pharmaceuticals Inc. | 15 | $241 |
| Alkermes, Inc. | 20 | $202 |
| Otsuka America Pharmaceutical, Inc. | 10 | $146 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
| Tris Pharma Inc | 3 | $58 |
| Lundbeck LLC | 2 | $41 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, REXULTI, HETLIOZ, FANAPT, AUSTEDO XR, Dyanavel XR.
Industry payments across IN — which companies pay providers there.
